TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.

Keith W Pratz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.